Similar articles

• [Broncho-Vaxom in the treatment of chronic pulmonary lesions].

  Basacopol A. Basacopol A. Pneumoftiziologia. 1992 Jan-Mar;41(1):25-30. Pneumoftiziologia. 1992. PMID: 1299395 Romanian.
• [The use of broncho-vaxom preparation in clinical practice].

  Mierzejewska-Zawisza MJ, Jahnz-Rózyk K, Rabczuk J. Mierzejewska-Zawisza MJ, et al. Pol Merkur Lekarski. 2003 May;14(83):457-8. Pol Merkur Lekarski. 2003. PMID: 12939827 Review. Polish.
• Immunomodulating drugs in pneumology.

  Catena E. Catena E. Sarcoidosis. 1989 Mar;6(1):II-VII. Sarcoidosis. 1989. PMID: 2657918 Review. No abstract available.
• [Comparative effectiveness of immunomodulators in the therapy of bronchopulmonary diseases].

  Zemskov AM, Provotorov VM, Nikitin AV, Zemskov VM. Zemskov AM, et al. Antibiotiki. 1984 Sep;29(9):673-6. Antibiotiki. 1984. PMID: 6508258 Russian.
• [Immune reactivity and immunomodulator-induced changes in bronchopulmonary infections].

  Algeorge G, Stoian M, Petre A, Bănică D, Molan M, Bercea O, Morgenstern H. Algeorge G, et al. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1987 Jan-Mar;36(1):57-66. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1987. PMID: 3033801 Romanian. No abstract available.